Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve A meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 27th October,2026 inter alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September, 2026.

Date: 14th October, 2026 To To The Listing Department The Listing Department National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, Floor 25, P. J. Towers, Bandra – Kurla Complex Dalal Street, Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Stock Code : 532612 Stock Code : INDOCO Dear Sir/Madam, Subject: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We wish to inform you that pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 27th October,2026 inter alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September, 2026. Further to our notice dated 28th September, 2026 relating to intimation of closure of trading window, Trading Window for dealing in Equity Shares of Indoco Remedies Limited shall remain closed for the Designated Persons and their immediate relatives until 29th October, 2026 i.e. 48 hours after the declaration of Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September, 2026. Thanking you, Yours faithfully, For Indoco Remedies Limited Ramanathan Hariharan Company Secretary & Head Legal